Punit Dhillon

Insider profile

Currently holds positions in Skye Bioscience, Inc., OncoSec Medical Inc and Arch Therapeutics Inc

Positions

Position Company Period
Chairman of the Board Skye Bioscience, Inc. Dec. 17, 2019 -
Director OncoSec Medical Inc May 2, 2018 -
Independent Director Arch Therapeutics Inc July 19, 2018 -
Independent Director Skye Bioscience, Inc. Dec. 31, 2017 - Dec. 17, 2019
President, Director OncoSec Medical Inc Nov. 7, 2017 - May 2, 2018
President, Chief Executive Officer, Director OncoSec Medical Inc March 10, 2011 - Nov. 7, 2017
Punit Dhillon's trades of Skye Bioscience, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
320.26
Quantity 59,376 -31.1%
Value US$3,193,224
Transaction date
Sale
Price
264.63
Quantity 78,494 +29.1%
Value US$2,544,843
Transaction date
Proposed sale
Price
478.98
Quantity 79,993
Value US$4,538,891
Transaction date
Purchase
Price
0.02
Quantity 881,000 +2.2%
Value US$16,475
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-19 2024-11-18
S Sale
59,376 -31.1%
320.26
US$3,193,224 		59,376 -31.1% 320.26 US$3,193,224
2024-11-19 2024-11-15
S Sale
78,494 +29.1%
264.63
US$2,544,843 		78,494 +29.1% 264.63 US$2,544,843
2024-11-15 2024-11-15
PrS Proposed sale
79,993
478.98
US$4,538,891 		79,993 478.98 US$4,538,891
2023-08-29 2023-08-29
B Purchase
881,000 +2.2%
0.02
US$16,475 		881,000 +2.2% 0.02 US$16,475